Investing.com - Zimmer Biomet reported on Monday fourth quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Zimmer Biomet announced earnings per share of $1.95 on revenue of $2.04B. Analysts polled by Investing.com anticipated EPS of $1.98 on revenue of $2.07B.
Zimmer Biomet shares are down 3% from the beginning of the year, still down 31.90% from its 52 week high of $180.36 set on April 29, 2021. They are outperforming the S&P 500 which is down 5.57% from the start of the year.
Zimmer Biomet follows other major Healthcare sector earnings this month
Zimmer Biomet's report follows an earnings beat by UnitedHealth on January 19, who reported EPS of $4.48 on revenue of $73.74B, compared to forecasts EPS of $4.3 on revenue of $72.98B.
J&J had beat expectations on January 25 with fourth quarter EPS of $2.13 on revenue of $24.8B, compared to forecast for EPS of $2.12 on revenue of $25.28B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar